Are Patients With End-Stage Liver Disease Maximally Vasodilated?

Autor:	Ahmed Aljizeeri, Awadelkarim Elneama, Mouaz H. Al-Mallah, Mousa Alfaris, Dalia Ahmed, Mohsen Alharthi, Ahmed Alsaileek, Ihab Suliman, Jabir Farea, Amjad M. Ahmed
Rok vydání:	2019
Předmět:	medicine.medical_specialty medicine.diagnostic_test business.industry medicine.medical_treatment Retrospective cohort study 030204 cardiovascular system & hematology Liver transplantation medicine.disease 030218 nuclear medicine & medical imaging Coronary artery disease Rubidium-82 03 medical and health sciences Liver disease Myocardial perfusion imaging 0302 clinical medicine Internal medicine Predictive value of tests medicine Cardiology Radiology Nuclear Medicine and imaging Cardiology and Cardiovascular Medicine business Perfusion
Zdroj:	JACC: Cardiovascular Imaging. 12:2583-2584
ISSN:	1936-878X
DOI:	10.1016/j.jcmg.2019.07.008
Popis:	Coronary artery disease (CAD) is a leading cause of mortality and morbidity among patients with end-stage liver disease (ESLD) undergoing liver transplantation ([1][1]). The increasing age and burden of traditional CAD risk factors in ESLD patients ([2][2]) warrants accurate risk stratification
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b17b17599c770ab705e1cb6154750f99 https://doi.org/10.1016/j.jcmg.2019.07.008 Zobrazit plný text záznamu